AzTrials
AzTrials

Premature BirthPTBNCT06340971

Air Pollution and Pregnancy

An observational study of Premature Birth, run by Queen Mary University of London at 2 sites in United Kingdom.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and child health, epidemiology, climate science, inflammation, computational modelling, machine learning and artificial intelligence. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Premature Birth
What is being tested?
Policy
How many people
200,000 participants
Where
2 sitesUnited Kingdom
Study dates
1 Nov 2024to 30 Nov 2029
How long will I take part?
1 Year
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Adult, Older adult

Study population: We aim to include data from pregnant women who delivered at UCLH from 2019 when EPIC was launched and until the end of 2023. There is no specified upper age range for this study. To improve inclusivity, we will aim to collect information from all women booking and delivering at UCLH to ensure minority ethnic groups and patients with social deprivation or with additional pregnancy complicating disorders are included within our dataset.

Who may be able to join

  • We aim to include data from pregnant women who delivered at University College London Hospitals from 2019 onwards after the start of the EPIC electronic patient record. The is no specified age range for this study, so as to improve inclusivity. We also aim to represent minority ethnic groups and patients with social deprivation within our dataset.

Who cannot join

  • We will exclude data from patients with an incomplete duration of follow-up due to transfer of antenatal care for delivery at another trust. Patients with incomplete past obstetric history data, inaccurate estimations of gestational age (e.g. due to late booking of the pregnancy) and missing data for 'postcode of usual address' will also be excluded. Patients who are less than 18 years of age will be excluded.

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

United Kingdom2 sites, 2 recruiting
  • Tina Chowdhury

    London, E14NS

    Tina Chowdhury, 0207882 ext. 7560, t.t.chowdhury@qmul.ac.uk

    Rhona Atkins, 0207882 ext. 7272, rhona.atkin@nhs.net

    Recruiting
  • Anna David

    London, NW1 2PG

    Yaa Acheampong, 020 3447 ext. 6164, y.acheampong@nhs.net

    Anna David, 0203 447 ext. 9400, a.david@nhs.net

    Recruiting

Other trials in United Kingdom

About this study

Official title: The Effects of Air Pollution on Pregnancy and Adverse Birth Outcomes

We are an inter-disciplinary team of UK scientists with expertise in obstetrics, women's and child health, epidemiology, climate science, inflammation, computational modelling, machine learning and artificial intelligence. Together we have a long history with existing strengths underlying preterm birth research that crosses multiple disciplines and an excellent track record of publications and awards leading research in preterm birth.

We aim to develop and validate a deep learning model to predict the risk of preterm birth and other adverse pregnancy outcomes using data from EPIC electronic health records at University College London Hospital Trust (UCLH) for a cohort of 18000 patients. We will obtain corresponding data on exposure to ambient pollution using non-identifiers for postcode (area) and date of delivery (month). The model will review the temporal sequence of events within a patient's medical history and current pregnancy, identifying significant interactions and will predict the risk of preterm birth. It will also determine the threshold and gestation at which pollution exposure has the greatest impact.

Read the detailed description

Preterm birth is the leading cause of neonatal morbidity and mortality worldwide. Children born prematurely have higher rates of cerebral palsy, sensory deficits, learning disabilities and respiratory illness. In the UK, approximately 60,000 babies are born prematurely each year. This is equivalent to 1 in 9 pregnancies in England and the numbers increase to 1 in every 7 pregnancies in London. In around 40% of cases, the cause of preterm birth are unknown. Current algorithms to predict preterm birth are limited in their ability to identify women at highest risk of delivering preterm and do not consider genetic, lifestyle and environmental circumstances within their prediction. With the rapid development of machine learning and deep learning, it is now possible to develop models which can consider a higher number of variables within their predictive algorithm, to formulate a patient specific prediction of risk. There is growing evidence that maternal exposure to air pollution during pregnancy is associated with an increased risk of preterm birth. Exposure to air pollution may be associated with poor placental function, pre-eclampsia, and poor fetal growth although there is limited data on these adverse pregnancy outcomes, all of which can lead to preterm birth. At present, many of the recent epidemiological studies in this area lack detailed and matching clinical data sets without gaps in electronic records.

This study aims to:

  1. Link data on air pollution exposure with highly detailed clinical data sets extracted from patient electronic health records from University College London Hospital NHS Trust (UCLH)
  2. Develop a computational model which can accurately predict the gestation at which a patient will deliver in weeks and days
  3. Using the model, identify the timepoints in pregnancy that air pollution has the greatest impact on pregnancy outcomes
Conditions
Premature Birth
Being tested
Policy
Keywords
Preterm birth, Pregnancy, Premature birth, Air pollution, Air quality
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PolicyOther

    We will work with stakeholders' policy groups e.g. RCOG, RCM, RCP and policy makers e.g. Department for Health and Social Care, Transport Emissions at the Greater London Authority or Mayor of London's office to disseminate our findings and develop public health messages.

    We aim to develop guidance on how pregnant women and their families can reduce their exposure to air pollution by highlighting for example travel routes with less pollution and wear face masks.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Machine learning model to predict the risk of preterm birth and adverse birth outcomes

    We aim to develop a deep learning algorithm to predict the risk of preterm birth and other adverse pregnancy outcomes using data from electronic health records and a spatiotemporal model for ambient pollution levels within London. The model will consider personal, lifestyle and environmental factors alongside traditional risk factors to predict the gestation of pregnancy that delivery is most likely to occur. This can be classified as 'term', 'late preterm', 'moderate preterm', 'very preterm' and 'extreme preterm'.

    Measured: 36 months

Secondary outcomes (1)
  1. Machine learning model to predict how air quality increases the risk of preterm birth and adverse birth outcomes

    This model will also review the temporal sequence of events within a patient's medical history and current pregnancy, identifying significant interactions. Other adverse pregnancy outcomes such as birthweight, birthweight centile, pre-eclampsia, small for gestational age, fetal growth restriction will also be studied.

    Measured: 42 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Apr 2024
  2. Study start1 Nov 2024
  3. Primary completion31 Oct 2029 (estimated)
  4. Study completion30 Nov 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
200,000 participants (estimated)
Target duration
1 Year
IDs, dates and publications
ClinicalTrials.gov ID
NCT06340971
Sponsor's protocol ID
331247
Acronym
PTB
Status last verified
Nov 2025
First submitted
26 Mar 2024
Last updated
24 Nov 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Data from the EPIC electronic health records database will be anonymized at UCLH to create a secondary dataset with anonymized identifier for patient identifier, postcode (area) and delivery date (month). Raw data screened. Patients excluded according to criteria.

Questions about this trial

What is this clinical trial studying?

An observational study of Premature Birth, run by Queen Mary University of London at 2 sites in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Machine learning model to predict the risk of preterm birth and adverse birth outcomes (time frame: 36 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in